Abstract
Minimal inhibitory concentration and disk diffusion susceptibility studies were carried out with oxolinic acid to determine a recommended disk content for disk susceptibility testing. Regression curve analyses were performed with disks containing 1, 2, and 5 μg of oxolinic acid. Data suggest that the 5-μg disk more satisfactorily fulfills requirements for susceptibility testing than the 1- or 2-μg disks evaluated. Ultraviolet spectral analysis studies for absorption maxima and extinction coefficients were done to verify the authenticity and concentration of oxolinic acid in the aqueous solutions studied.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atlas E., Clark H., Silverblatt F., Turck M. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Ann Intern Med. 1969 Apr;70(4):713–721. doi: 10.7326/0003-4819-70-4-713. [DOI] [PubMed] [Google Scholar]
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Cox C. E. Oxolinic acid therapy of recurrent urinary tract infections. Del Med J. 1970 Nov;42(11):327–passim. [PubMed] [Google Scholar]
- Ericsson H. M., Sherris J. C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;217(Suppl):1+–1+. [PubMed] [Google Scholar]
- Kaminsky D., Meltzer R. I. Quinolone antibacterial agents. Oxolinic acid and related compounds. J Med Chem. 1968 Jan;11(1):160–163. doi: 10.1021/jm00307a041. [DOI] [PubMed] [Google Scholar]
- Matsen J. M., Lund M. E., Brooker D. C. Comparison and evaluation of carbenicillin disks in diffusion susceptibility testing. Antimicrob Agents Chemother. 1974 Jun;5(6):599–606. doi: 10.1128/aac.5.6.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neussel H., Linzenmeier G. In vitro investigations with oxolinic acid, a new chemotherapeutic agent. Chemotherapy. 1973;18(4):253–261. doi: 10.1159/000221269. [DOI] [PubMed] [Google Scholar]
